Growth Metrics

Neogenomics (NEO) Current Deferred Tax Assets (2016)

Historic Current Deferred Tax Assets for Neogenomics (NEO) over the last 4 years, with Q4 2016 value amounting to $1.2 million.

  • Neogenomics' Current Deferred Tax Assets fell 9250.72% to $1.2 million in Q4 2016 from the same period last year, while for Dec 2016 it was $1.2 million, marking a year-over-year decrease of 9250.72%. This contributed to the annual value of $1.2 million for FY2016, which is 9250.72% down from last year.
  • Latest data reveals that Neogenomics reported Current Deferred Tax Assets of $1.2 million as of Q4 2016, which was down 9250.72% from $8.5 million recorded in Q2 2016.
  • In the past 5 years, Neogenomics' Current Deferred Tax Assets registered a high of $16.7 million during Q4 2015, and its lowest value of $588000.0 during Q4 2013.
  • Moreover, its 4-year median value for Current Deferred Tax Assets was $821000.0 (2014), whereas its average is $4.1 million.
  • As far as peak fluctuations go, Neogenomics' Current Deferred Tax Assets skyrocketed by 193020.71% in 2015, and later crashed by 9250.72% in 2016.
  • Quarter analysis of 4 years shows Neogenomics' Current Deferred Tax Assets stood at $588000.0 in 2013, then skyrocketed by 39.63% to $821000.0 in 2014, then skyrocketed by 1930.21% to $16.7 million in 2015, then plummeted by 92.51% to $1.2 million in 2016.
  • Its Current Deferred Tax Assets was $1.2 million in Q4 2016, compared to $8.5 million in Q2 2016 and $16.7 million in Q1 2016.